1.115

1.82% 0.015

Inovio Pharmaceuticals Inc (INO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.10

Aprire:

$1.1

Volume 24 ore:

580.65K

Relative Volume:

0.22

Capitalizzazione di mercato:

$91.73M

Reddito:

$65,300

Utile/perdita netta:

$-84.93M

Rapporto P/E:

-0.6528

EPS:

-1.708

Flusso di cassa netto:

$-83.57M

1 W Prestazione:

+4.67%

1M Prestazione:

-20.57%

6M Prestazione:

-45.63%

1 anno Prestazione:

-46.15%

Intervallo 1D:

$1.10

$1.15

Intervallo di 1 settimana:

$1.06

$1.15

Portata 52W:

$1.03

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Nome

Inovio Pharmaceuticals Inc

Settore

Healthcare (1101)

Industria

Biotechnology (616)

Telefono

(858) 410-3134

Indirizzo

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Dipendente

112

Cinguettio

@inoviopharma

Prossima data di guadagno

2026-05-13

Ultimi documenti SEC

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INO Inovio Pharmaceuticals Inc	1.115	90.50M	65,300	-84.93M	-83.57M	-1.708
VRTX Vertex Pharmaceuticals Inc	442.95	112.95B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	611.39	64.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	905.64	55.90B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	287.50	38.64B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	153.35	31.73B	742.00K	-1.37B	-1.07B	-7.0731

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-09	Iniziato	Piper Sandler	Overweight
2024-05-14	Iniziato	Stephens	Overweight
2024-01-25	Aggiornamento	Oppenheimer	Perform → Outperform
2022-11-09	Downgrade	Maxim Group	Buy → Hold
2022-11-01	Downgrade	BofA Securities	Neutral → Underperform
2022-07-19	Ripresa	RBC Capital Mkts	Sector Perform
2022-05-11	Downgrade	Oppenheimer	Outperform → Perform
2022-01-21	Aggiornamento	BofA Securities	Underperform → Neutral
2021-12-29	Ripresa	Jefferies	Hold
2021-09-10	Downgrade	BofA Securities	Neutral → Underperform
2021-06-24	Iniziato	Jefferies	Hold
2021-03-23	Iniziato	BofA Securities	Neutral
2021-02-12	Iniziato	Oppenheimer	Outperform
2020-11-17	Downgrade	ROTH Capital	Neutral → Sell
2020-11-10	Aggiornamento	ROTH Capital	Sell → Neutral
2020-09-28	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Aggiornamento	Maxim Group	Hold → Buy
2020-07-01	Downgrade	Maxim Group	Buy → Hold
2020-07-01	Downgrade	ROTH Capital	Neutral → Sell
2020-06-29	Downgrade	H.C. Wainwright	Buy → Neutral
2020-06-26	Downgrade	Stifel	Buy → Hold
2020-05-21	Iniziato	The Benchmark Company	Buy
2020-04-30	Downgrade	ROTH Capital	Buy → Neutral
2020-03-13	Downgrade	Piper Sandler	Overweight → Neutral
2020-03-13	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Iniziato	ROTH Capital	Buy
2018-02-15	Reiterato	Maxim Group	Buy
2017-10-18	Iniziato	RBC Capital Mkts	Outperform
2017-09-06	Iniziato	Citigroup	Buy
2017-06-08	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-05-24	Reiterato	Maxim Group	Buy
2017-03-16	Aggiornamento	Maxim Group	Hold → Buy
2017-03-16	Downgrade	Piper Jaffray	Overweight → Neutral

Mostra tutto

Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie

Jun 10, 2026

Inovio Pharmaceuticals(INO) Stock Options Chain | Quotes & News - Moomoo

Jun 10, 2026

Jun 09, 2026

Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus

Jun 09, 2026

Jun 08, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 08, 2026

INO stock edges up after hours as partner reports success in cervical dysplasia trial - MSN

Jun 08, 2026

INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits

Jun 08, 2026

Jun 05, 2026

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jun 05, 2026